Literature DB >> 29872140

Antibodies and tuberculosis: finally coming of age?

Hao Li1, Babak Javid2.   

Abstract

Are antibodies important for protection against tuberculosis? The jury has been out for more than 100 years. B cell depletion in experimental Mycobacterium tuberculosis infection failed to identify a major role for these cells in immunity to tuberculosis. However, recent identification of naturally occurring antibodies in humans that are protective during M. tuberculosis infection has reignited the debate. Here, we discuss the evidence for a protective role for antibodies in tuberculosis and consider the feasibility of designing novel tuberculosis vaccines targeting humoral immunity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29872140     DOI: 10.1038/s41577-018-0028-0

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  28 in total

Review 1.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

2.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 3.  BCG vaccination strategies against tuberculosis: updates and perspectives.

Authors:  Mengjin Qu; Xiangmei Zhou; Hao Li
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

4.  Effects of anticoagulants and Ficoll on human serum antibody reactivities and functions against Mycobacterium tuberculosis.

Authors:  Nicholas J Gadsden; Yanyan Liu; Stephanie Gati; Tingting Chen; Elizabeth R Jenny-Avital; Jacqueline M Achkar
Journal:  Tuberculosis (Edinb)       Date:  2020-01-10       Impact factor: 3.131

Review 5.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

Review 6.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

7.  Antibodies: what makes us stronger.

Authors:  Natalia T Freund
Journal:  Hum Vaccin Immunother       Date:  2021-05-25       Impact factor: 4.526

8.  Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.

Authors:  Ju Mi Lee; Jiyun Park; Steven G Reed; Rhea N Coler; Jung Joo Hong; Lee-Han Kim; Wonsik Lee; Kee Woong Kwon; Sung Jae Shin
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 9.  [New vaccines against tuberculosis].

Authors:  Stefan H E Kaufmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-01       Impact factor: 1.513

10.  Sex influences the association between haemostasis and the extent of lung lesions in tuberculosis.

Authors:  Wenling Tan; Adiilah K Soodeen-Lalloo; Yue Chu; Weijie Xu; Fengfang Chen; Jie Zhang; Wei Sha; Jin Huang; Guanghong Yang; Lianhua Qin; Jie Wang; Xiaochen Huang; Jingyun Shi; Yonghong Feng
Journal:  Biol Sex Differ       Date:  2018-10-10       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.